Moneycontrol Be a Pro
Get App
SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > Pharmaceuticals > Nine Months - Fresenius Kabi Oncology

Fresenius Kabi Oncology

BSE: 532545|NSE: FKONCO|ISIN: INE575G01010|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
Fresenius Kabi Oncology is not traded in the last 30 days
Fresenius Kabi Oncology is not traded in the last 30 days
Download Annual Report PDF Format 2013 | 2012 | 2011 | 2010

Nine Months of Fresenius Kabi Oncology

------------------- in Rs. Cr. -------------------
Dec '13 Dec '12 Dec '11 Dec '10 Dec '09
Net Sales/Income from operations 207.78 425.70 366.40 322.50 305.88
Other Operating Income 99.90 77.36 36.13 -- --
Total Income From Operations 307.68 503.06 402.53 322.50 305.88
EXPENDITURE
Consumption of Raw Materials 124.52 140.19 140.42 100.88 111.46
Purchase of Traded Goods 4.94 2.77 2.40 1.84 --
Increase/Decrease in Stocks -32.24 3.50 28.27 5.35 -26.93
Power & Fuel -- -- -- -- --
Employees Cost 55.87 52.92 43.11 41.39 32.53
Depreciation 22.78 19.26 17.91 11.61 9.62
Excise Duty -- -- -- -- --
Admin. And Selling Expenses -- -- -- -- --
R & D Expenses 84.96 85.77 48.38 30.46 25.04
Provisions And Contingencies -- -- -- -- --
Exp. Capitalised -- -- -- -- --
Other Expenses 126.75 86.27 84.66 56.87 75.98
P/L Before Other Inc. , Int., Excpt. Items & Tax -79.91 112.39 37.37 74.09 78.18
Other Income 7.06 0.98 1.24 2.64 5.31
P/L Before Int., Excpt. Items & Tax -72.85 113.37 38.61 76.73 83.50
Interest 12.58 -0.54 8.90 13.20 15.87
P/L Before Exceptional Items & Tax -85.42 113.91 29.70 63.53 67.63
Exceptional Items -- -- -- -- --
P/L Before Tax -85.42 113.91 29.70 63.53 67.63
Tax 5.75 25.56 7.20 19.93 10.06
P/L After Tax from Ordinary Activities -91.18 88.35 22.51 43.60 57.57
Prior Year Adjustments -- -- -- -- --
Extra Ordinary Items -12.44 -- 26.76 2.68 4.59
Net Profit/(Loss) For the Period -103.62 88.35 49.27 46.28 62.16
Equity Share Capital 15.82 15.82 15.82 15.82 15.82
Reserves Excluding Revaluation Reserves -- -- -- -- --
Equity Dividend Rate (%) -- -- -- -- --
EPS Before Extra Ordinary
Basic EPS -5.76 5.58 1.42 2.76 --
Diluted EPS -5.76 5.58 1.42 2.76 --
EPS After Extra Ordinary
Basic EPS -6.55 5.58 3.11 2.92 --
Diluted EPS -6.55 5.58 3.11 2.92 --
Public Share Holding
No Of Shares (Crores) 1.32 3.01 1.58 1.58 1.58
Share Holding (%) 8.31 19.00 10.00 10.00 10.00
Promoters and Promoter Group Shareholding
a) Pledged/Encumbered
- Number of shares (Crores) -- -- -- -- --
- Per. of shares (as a % of the total sh. of prom. and promoter group) -- -- -- -- --
- Per. of shares (as a % of the total Share Cap. of the company) -- -- -- -- --
b) Non-encumbered
- Number of shares (Crores) 14.51 12.82 14.24 14.24 --
- Per. of shares (as a % of the total sh. of prom. and promoter group) 100.00 100.00 100.00 100.00 --
- Per. of shares (as a % of the total Share Cap. of the company) 91.69 81.00 90.00 90.00 --
Notes
Source : Dion Global Solutions Limited

Results of Fresenius Kabi

  • News
  • Results
  • Estimates
  • Analysis
No news.

Results of Pharmaceuticals Sector

  • News
  • Results
  • Estimates
  • Analysis
No news.
Quick Links for freseniuskabioncology
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.